Navigation Links
AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles

Second generation pyridopyrazine-urea derivative compound series show highly selective PI3K-inhibition which could be valuable for cancer treatment

QUEBEC, April 16, 2007 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. , a global, pure play biopharmaceutical company focused on endocrine therapy and oncology, today presented an abstract outlining first in vitro data on its pyridopyrazine derivatives with high selectivity for PI3K inhibition, at the American Association for Cancer Research (AACR) Annual Meeting being held this week at the Los Angeles Convention Center in Los Angeles, California.

Results

The poster #2379 entitled, "New Generation of Anilino-Substituted Pyridopyrazine-Urea Derivatives Show Highly Selective PI3K-Inhibition", reviewed for the first time, results for a preclinical development program on a new generation of pyridopyrazine derivatives which clearly indicate that these drug candidates selectively inhibit PI3K.

Furthermore, an optimization process of our already known aryl-pyridopyrazine series led to the identification of a new lead compound in this series. A medicinal chemistry program was then initiated which resulted in the synthesis of new anilino-substituted pyridopyrazines. Out of this second generation series, several derivatives also with highly-selective PI3K inhibition as well as improved cellular efficacy and better drug-like properties, were identified.

    Conclusions


         - Novel low molecular weight kinase inhibitor

         - Excellent in vitro activity against PI3K

         - High selectivity against a panel of more than 50 kinases

         - Anti-proliferative efficacy in diverse tumor cell-lines

         - Promising bioavailability observed for lead compound

         - PI3K signalling network covers enormous therapeutic potential

"We are pleased with these results which exemplify our capability of developing novel the
'"/>




Page: 1 2 3

Related medicine technology :

1. AEterna Zentaris Partner Keryx Presents Phase 1 and Phase 2 Results for Anti-Cancer Compound Perifosine at ASCO Meeting
2. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
3. AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist JMR-132 at the AACR Annual Meeting in Los Angeles
4. AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors and In Vivo Results for a GHRH Antagonist at the AACR Annual Meeting in Los Angeles
5. AEterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a Trial
6. terna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los Angeles
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
9. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
10. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
11. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
Post Your Comments:
(Date:9/18/2014)... 18, 2014 MiMedx Group, Inc. (NASDAQ: ... and marketer of patent protected regenerative biomaterials and ... that it has entered into a distribution agreement ... provide its dehydrated human amnion/chorion membrane ("dHACM") allograft ... on a private label basis. The ...
(Date:9/18/2014)... ANN ARBOR, Mich. , Sept. 18, 2014 /PRNewswire-USNewswire/ ... Medical Research will allow the University of Michigan to ... The Glenn Center for Aging Research ... growing evidence that drugs can slow the effects of ... to unlock mechanisms of aging that can help develop ...
(Date:9/18/2014)... announces the list of stocks featured in the Analyst ... the latest news and events impacting stocks and the ... Avanir Pharmaceuticals (Nasdaq: AVNR - Free Report ), ... Orexigen (Nasdaq: OREX - Free Report ), Medivation ... (Nasdaq: GILD - Free Report ). ...
Breaking Medicine Technology:MiMedx Signs Distribution Agreement With Zimmer 2MiMedx Signs Distribution Agreement With Zimmer 3$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 2$3 M grant funds Paul F. Glenn Center for Aging Research at the University of Michigan 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 2The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 4The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 5The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 6
... ANGELES, Sept. 29, 2011 A west coast secret is ... All the way from Beverly Hills, California, a health and ... headlines ( www.endlessyouthandlife.com ).  A clinically tested dietary supplement is ... shown in less than 4 weeks of use.  Just a ...
... Awarepoint Corporation , the leading provider ... announced today that it received Frost & Sullivan,s ... Strategy Leadership Award .  The award recognizes ... and workflow automation solutions that significantly differentiates Awarepoint ...
Cached Medicine Technology:Beverly Hills Secret Now Helping People Across The Country 2Awarepoint Corporation Receives Frost & Sullivan's 2011 North American RFID and RTLS Healthcare Competitive Strategy Leadership Award 2Awarepoint Corporation Receives Frost & Sullivan's 2011 North American RFID and RTLS Healthcare Competitive Strategy Leadership Award 3
(Date:9/18/2014)... Relias Learning, the leader in SaaS-based training and ... announced it has been named to the Inc. 5000 list ... , In the three-year period from 2010 to 2013, Relias ... on the Inc. 5000 list to 1,025 from the company’s ... we serve continue to grow, and the need for quality ...
(Date:9/18/2014)... PlatinumCode, a leading manufacturer and ... for the healthcare industry, announced earlier this month ... of their profits of the sale of eligible ... the announcement, PlatinumCode has launched various marketing efforts ... and hospital labs with their popular “Pink Packs” ...
(Date:9/18/2014)... “Awesome” is the way Emily W. describes ... Today) Internship Program at ARDX ( http://www.ardx.net ). ... program as “Inspirational” and “Life-changing,” respectively. None of ... would be doing during their summer internship. Stacie ... other mindless tasks,” but, instead she was doing real, ...
(Date:9/18/2014)... HealthDay Reporter WEDNESDAY, Sept. ... number of post-traumatic stress disorder symptoms are almost three times ... study suggests. The findings don,t prove a direct ... food. And it,s also possible that certain women are prone ... Still, the research seems to add to existing evidence ...
(Date:9/18/2014)... Fit Body Boot Camp , an internationally ... the country and its popularity, as both a franchise and ... in 2014. , The company’s annual business conference, the ... Costa Mesa, CA on September 26 and 27, and is ... Bedros Keuilian, who is also considered the leading fitness marketing ...
Breaking Medicine News(10 mins):Health News:Relias Learning Named to Inc. 5000 List for Second Consecutive Year 2Health News:PlatinumCode Commits to Donating Five Percent of Profits from the sale of Pink Products to Support Breast Cancer Awareness 2Health News:ARDX Internship Helps Students to START on the Right Business Path 2Health News:ARDX Internship Helps Students to START on the Right Business Path 3Health News:ARDX Internship Helps Students to START on the Right Business Path 4Health News:PTSD Link to Food Addiction Seen in Report 2Health News:PTSD Link to Food Addiction Seen in Report 3Health News:With Fit Body Boot Camp World Conference Nearing, Founder Explains the Fitness Boot Camp Franchise’s Success 2Health News:With Fit Body Boot Camp World Conference Nearing, Founder Explains the Fitness Boot Camp Franchise’s Success 3
... MONDAY, Oct. 31 (HealthDay News) --,The longer they live in ... immigrants will develop health problems, a new study says. ... Nutrition Examination Survey and discovered a dramatic increase in obesity, ... in the United States for more than 20 years. ...
... developed a new way to assess a common cause ... Disease Activity Index. A study describing the index was ... Annual Scientific Meeting and Postgraduate Course in Washington. The ... severity. "Until now, physicians have not ...
... on nutrients carried to them by the blood stream. ... hallmark of cancer, and studies have shown that preventing ... To better understand the relationship between cancer and the ... of the complete network of blood vessels in organs. ...
... Tech-savvy teens with acne used their medicine more frequently ... a new study from Wake Forest Baptist Medical Center ... test whether a weekly Internet-based communication could improve teenagers, ... "Dermatologists have a number of effective topical agents for ...
... Surgeons at UK HealthCare recently became the first ever to ... transplantation. Wanda Craig, of Lexington, Ky., is the first patient ... of 68, she is also the oldest living human to ... known as an extracorporeal membrane oxygenation (ECMO). For more ...
... could help GPs to speed up the diagnosis and ... common forms of cancer, potentially saving thousands of lives ... and ClinRisk Ltd have shown that the algorithm is ... lung cancer at an earlier stage by ,red-flagging, potentially ...
Cached Medicine News:Health News:Life in U.S. Not Always a Plus for Immigrants' Health 2Health News:The power of the Internet: It helps improve teens' acne 2Health News:UK HealthCare surgeons are first to perform novel procedures prior to transplant 2Health News:UK HealthCare surgeons are first to perform novel procedures prior to transplant 3Health News:Computer-based tool to improve diagnosis and prognosis for cancer patients 2Health News:Computer-based tool to improve diagnosis and prognosis for cancer patients 3Health News:Computer-based tool to improve diagnosis and prognosis for cancer patients 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: